| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10968517 | Vaccine | 2013 | 4 Pages |
Abstract
⺠A new recombinant vaccine against meningococci group B is under registration. ⺠We examined coverage of group X isolates emerging in Africa (no available vaccine). ⺠Vaccine components are conserved and expressed in African serogroup X isolates. ⺠Sera from vaccinated subjects killed effectively serogroup X isolates. ⺠The vaccine can further be investigated to control serogroup X outbreaks.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Eva Hong, Marzia Monica Giuliani, Ala-Eddine Deghmane, Maurizio Comanducci, Brunella Brunelli, Peter Dull, Mariagrazia Pizza, Muhamed-Kheir Taha,